Marcus M Schittenhelm (Marcus Schittenhelm)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Locally Advanced

Transcription Factor

Top Venues

Cell death & disease

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Marcus M Schittenhelm, Max Kaiser, Balázs Győrffy, Kerstin M Kampa-Schittenhelm
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML). Cell death & disease 15 (1) (2024)
Marcus M Schittenhelm, Max Kaiser, Balázs Győrffy, Kerstin M Kampa-Schittenhelm
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML). Cell death & disease 15 (1) (2024)
Marcus M Schittenhelm, Max Kaiser, Balázs Győrffy, Kerstin M Kampa-Schittenhelm
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML). Cell death & disease 15 (1) (2024)
Marcus M Schittenhelm, Max Kaiser, Balázs Győrffy, Kerstin M Kampa-Schittenhelm
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML). Cell death & disease 15 (1) (2024)
Johannes Kliebhan, Andrej Besse, Kerstin M Kampa-Schittenhelm, Marcus M Schittenhelm, Christoph Driessen
Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma. Clinical case reports 10 (10) (2022)